Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1876 1
1877 3
1878 2
1879 1
1880 3
1881 8
1882 1
1886 2
1887 1
1908 1
1912 1
1930 2
1946 2
1947 2
1948 1
1953 2
1954 2
1956 1
1957 2
1958 1
1959 1
1960 2
1961 1
1962 4
1964 1
1965 2
1966 3
1967 3
1968 2
1969 2
1970 2
1971 1
1972 1
1973 3
1974 2
1975 3
1976 1
1977 4
1978 2
1979 3
1980 3
1981 5
1982 4
1983 4
1984 6
1985 4
1986 12
1987 3
1988 7
1989 4
1990 5
1991 8
1992 9
1993 3
1994 8
1995 8
1996 7
1997 6
1998 2
1999 11
2000 9
2001 8
2002 5
2003 16
2004 14
2005 14
2006 13
2007 14
2008 18
2009 15
2010 26
2011 31
2012 29
2013 35
2014 36
2015 35
2016 29
2017 32
2018 31
2019 32
2020 45
2021 32
2022 30
2023 24
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

711 results

Results by year

Filters applied: . Clear all
Page 1
Host-microbiota maladaptation in colorectal cancer.
Janney A, Powrie F, Mann EH. Janney A, et al. Among authors: mann eh. Nature. 2020 Sep;585(7826):509-517. doi: 10.1038/s41586-020-2729-3. Epub 2020 Sep 23. Nature. 2020. PMID: 32968260 Review.
IL-1-driven stromal-neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapies.
Friedrich M, Pohin M, Jackson MA, Korsunsky I, Bullers SJ, Rue-Albrecht K, Christoforidou Z, Sathananthan D, Thomas T, Ravindran R, Tandon R, Peres RS, Sharpe H, Wei K, Watts GFM, Mann EH, Geremia A, Attar M; Oxford IBD Cohort Investigators; Roche Fibroblast Network Consortium; McCuaig S, Thomas L, Collantes E, Uhlig HH, Sansom SN, Easton A, Raychaudhuri S, Travis SP, Powrie FM. Friedrich M, et al. Among authors: mann eh. Nat Med. 2021 Nov;27(11):1970-1981. doi: 10.1038/s41591-021-01520-5. Epub 2021 Oct 21. Nat Med. 2021. PMID: 34675383 Free PMC article.
Microbiota Sensing by Mincle-Syk Axis in Dendritic Cells Regulates Interleukin-17 and -22 Production and Promotes Intestinal Barrier Integrity.
Martínez-López M, Iborra S, Conde-Garrosa R, Mastrangelo A, Danne C, Mann ER, Reid DM, Gaboriau-Routhiau V, Chaparro M, Lorenzo MP, Minnerup L, Saz-Leal P, Slack E, Kemp B, Gisbert JP, Dzionek A, Robinson MJ, Rupérez FJ, Cerf-Bensussan N, Brown GD, Bernardo D, LeibundGut-Landmann S, Sancho D. Martínez-López M, et al. Among authors: mann er. Immunity. 2019 Feb 19;50(2):446-461.e9. doi: 10.1016/j.immuni.2018.12.020. Epub 2019 Jan 29. Immunity. 2019. PMID: 30709742 Free PMC article.
BRCA Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma.
Lin KK, Harrell MI, Oza AM, Oaknin A, Ray-Coquard I, Tinker AV, Helman E, Radke MR, Say C, Vo LT, Mann E, Isaacson JD, Maloney L, O'Malley DM, Chambers SK, Kaufmann SH, Scott CL, Konecny GE, Coleman RL, Sun JX, Giordano H, Brenton JD, Harding TC, McNeish IA, Swisher EM. Lin KK, et al. Among authors: mann e. Cancer Discov. 2019 Feb;9(2):210-219. doi: 10.1158/2159-8290.CD-18-0715. Epub 2018 Nov 13. Cancer Discov. 2019. PMID: 30425037 Free article. Clinical Trial.
Fusobacterium nucleatum, rectal cancer and radiotherapy.
Mann EH, Maughan TS. Mann EH, et al. Ann Oncol. 2020 Oct;31(10):1277-1278. doi: 10.1016/j.annonc.2020.06.019. Epub 2020 Jul 4. Ann Oncol. 2020. PMID: 32629022 Free article. No abstract available.
Swollen toes.
Mann E, Kramer R, Clinch CR. Mann E, et al. J Fam Pract. 2017 Nov;66(11):697-698. J Fam Pract. 2017. PMID: 29099513
Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial.
Swisher EM, Lin KK, Oza AM, Scott CL, Giordano H, Sun J, Konecny GE, Coleman RL, Tinker AV, O'Malley DM, Kristeleit RS, Ma L, Bell-McGuinn KM, Brenton JD, Cragun JM, Oaknin A, Ray-Coquard I, Harrell MI, Mann E, Kaufmann SH, Floquet A, Leary A, Harding TC, Goble S, Maloney L, Isaacson J, Allen AR, Rolfe L, Yelensky R, Raponi M, McNeish IA. Swisher EM, et al. Among authors: mann e. Lancet Oncol. 2017 Jan;18(1):75-87. doi: 10.1016/S1470-2045(16)30559-9. Epub 2016 Nov 29. Lancet Oncol. 2017. PMID: 27908594 Free article. Clinical Trial.
711 results